TCT 2014: Medtronic's IN.PACT Admiral beats PTA in outcomes, costs

Medtronic unveils 1-year study results showing that its IN.PACT Admiral drug-coated balloon is clinically superior and more cost-effective than standard percutaneous transluminal angioplasty. Medtronic, TCT 2014News Well, Clinical Trials, Conference coverage, Minnesota, Peripheral Artery Disease, Transcatheter Cardiovascular Therapeutics symposium (TCT)read more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news